Hengrui Medicine (01276.HK): Cumulative repurchase of 8.8987 million shares of A shares as of the end of November.

Smart Financial News App, Hengrui Medicine (01276.HK) announced that as of November 2025, the company repurchased 979,000 shares of A-shares through the Shanghai Stock Exchange trading system through centralized bidding trading. The repurchased shares account for 0.015% of the company's total share capital, with the highest purchase price at RMB 63.28 per share and the lowest at RMB 59.32 per share. The total amount paid was RMB 59.7885 million (excluding transaction fees). As of November 30, 2025, the company's cumulative repurchase of shares in this program through the Shanghai Stock Exchange trading system through centralized bidding trading amounted to 8.8987 million shares, representing 0.13% of the company's total share capital. The highest purchase price was RMB 70.00 per share and the lowest was RMB 59.32 per share, with a total amount paid of RMB 595 million (excluding transaction fees).